On January 7, the government approved the emergency use of the Oxford-AstraZeneca Covid-19 vaccine.
The approval will allow Beximco Pharmaceuticals to bring doses from the Serum Institute of India, which is manufacturing the vaccine, Mohammad Salahuddin, deputy director of the Directorate General of Drug Administration, said.
On December 13, the government signed an agreement with Serum Institute for procuring Oxford-AstraZeneca Covid-19 vaccine.
Under the deal, Bangladesh will import 3 crore doses of SARS-Cov-2 AZD 1222 (Oxford-Astrazeneca vaccine) from Serum in the next six months.
“If everything goes well, we will get the vaccines in mid-January,” Health Minister Zahid Maleques said.
The process to bring Oxford-Astrazeneca vaccine would start in January next, said Zahid adding that a decision was taken in principle that Serum Institute would provide the vaccine at the same price they would procure it.